These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
FORM 10-Q
|
[X]
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
For the quarterly period ended September 27, 2014
|
[ ]
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
For the transition period from ________ to ________.
|
Delaware
(State or Other Jurisdiction of Incorporation or Organization)
|
|
94-2896096
(I.R.S. Employer I. D. No.)
|
Large accelerated filer [x]
|
Accelerated filer [ ]
|
Non-accelerated filer [ ]
(Do not check if a smaller reporting company) |
Smaller reporting company [ ]
|
|
|
|
|
|
PART I - FINANCIAL INFORMATION
|
|
Page
|
|
|
|
Item 1. Financial Statements (Unaudited)
|
|
|
|
|
|
Condensed Consolidated Balance Sheets as of September 27, 2014 and June 28, 2014
|
|
|
|
|
|
Condensed Consolidated Statements of Income for the Three Months Ended September 27, 2014 and September 28, 2013
|
|
|
|
|
|
Condensed Consolidated Statements of Comprehensive Income for the Three Months Ended September 27, 2014 and September 28, 2013
|
|
|
|
|
|
Condensed Consolidated Statements of Cash Flows for the Three Months Ended September 27, 2014 and September 28, 2013
|
|
|
|
|
|
Notes to Condensed Consolidated Financial Statements
|
|
|
|
|
|
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
|
|
|
|
|
Item 3. Quantitative and Qualitative Disclosures About Market Risk
|
|
|
|
|
|
Item 4. Controls and Procedures
|
|
|
|
|
|
PART II - OTHER INFORMATION
|
|
|
|
|
|
Item 1. Legal Proceedings
|
|
|
|
|
|
Item 1A. Risk Factors
|
|
|
|
|
|
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
|
|
|
|
|
|
Item 3. Defaults Upon Senior Securities
|
|
|
|
|
|
Item 4. Mine Safety Disclosures
|
|
|
|
|
|
Item 5. Other Information
|
|
|
|
|
|
Item 6. Exhibits
|
|
|
|
|
|
SIGNATURES
|
|
|
September 27,
2014 |
|
June 28,
2014 |
||||
|
(in thousands)
|
||||||
ASSETS
|
|||||||
Current assets:
|
|
|
|
||||
Cash and cash equivalents
|
$
|
1,243,883
|
|
|
$
|
1,322,472
|
|
Short-term investments
|
75,094
|
|
|
49,953
|
|
||
Total cash, cash equivalents and short-term investments
|
1,318,977
|
|
|
1,372,425
|
|
||
Accounts receivable, net
|
281,932
|
|
|
295,828
|
|
||
Inventories
|
305,108
|
|
|
289,292
|
|
||
Deferred tax assets
|
54,379
|
|
|
74,597
|
|
||
Other current assets
|
67,383
|
|
|
54,560
|
|
||
Total current assets
|
2,027,779
|
|
|
2,086,702
|
|
||
Property, plant and equipment, net
|
1,303,861
|
|
|
1,331,519
|
|
||
Intangible assets, net
|
337,917
|
|
|
360,994
|
|
||
Goodwill
|
595,441
|
|
|
596,637
|
|
||
Other assets
|
40,127
|
|
|
29,766
|
|
||
TOTAL ASSETS
|
$
|
4,305,125
|
|
|
$
|
4,405,618
|
|
|
|
|
|
||||
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|||||||
Current liabilities:
|
|
|
|
||||
Accounts payable
|
$
|
96,347
|
|
|
$
|
102,076
|
|
Income taxes payable
|
20,122
|
|
|
20,065
|
|
||
Accrued salary and related expenses
|
126,624
|
|
|
186,732
|
|
||
Accrued expenses
|
65,216
|
|
|
64,028
|
|
||
Deferred revenue on shipments to distributors
|
26,821
|
|
|
25,734
|
|
||
Total current liabilities
|
335,130
|
|
|
398,635
|
|
||
Long-term debt
|
1,001,026
|
|
|
1,001,026
|
|
||
Income taxes payable
|
350,396
|
|
|
362,802
|
|
||
Deferred tax liabilities
|
145,597
|
|
|
159,879
|
|
||
Other liabilities
|
61,572
|
|
|
53,365
|
|
||
Total liabilities
|
1,893,721
|
|
|
1,975,707
|
|
||
|
|
|
|
||||
Commitments and contingencies (Note 11)
|
|
|
|
|
|
||
|
|
|
|
||||
Stockholders’ equity:
|
|
|
|
||||
Common stock and capital in excess of par value
|
284
|
|
|
23,290
|
|
||
Retained earnings
|
2,430,194
|
|
|
2,423,794
|
|
||
Accumulated other comprehensive loss
|
(19,074
|
)
|
|
(17,173
|
)
|
||
Total stockholders’ equity
|
2,411,404
|
|
|
2,429,911
|
|
||
TOTAL LIABILITIES & STOCKHOLDERS’ EQUITY
|
$
|
4,305,125
|
|
|
$
|
4,405,618
|
|
|
Three Months Ended
|
||||||
|
September 27,
2014 |
|
September 28,
2013 |
||||
|
(in thousands, except per share data)
|
||||||
|
|
|
|
||||
Net revenues
|
$
|
580,275
|
|
|
$
|
585,241
|
|
Cost of goods sold
|
241,454
|
|
|
238,045
|
|
||
Gross margin
|
338,821
|
|
|
347,196
|
|
||
Operating expenses:
|
|
|
|
||||
Research and development
|
140,362
|
|
|
129,902
|
|
||
Selling, general and administrative
|
79,989
|
|
|
77,430
|
|
||
Intangible asset amortization
|
4,327
|
|
|
3,436
|
|
||
Impairment of long-lived assets
|
10,226
|
|
|
—
|
|
||
Severance and restructuring expenses
|
1,385
|
|
|
5,547
|
|
||
Other operating expenses (income), net
|
1,574
|
|
|
2,272
|
|
||
Total operating expenses
|
237,863
|
|
|
218,587
|
|
||
Operating income
|
100,958
|
|
|
128,609
|
|
||
Interest and other income (expense), net
|
(6,477
|
)
|
|
(3,463
|
)
|
||
Income before provision for income taxes
|
94,481
|
|
|
125,146
|
|
||
Income tax provision (benefit)
|
(5,499
|
)
|
|
22,026
|
|
||
Net income
|
$
|
99,980
|
|
|
$
|
103,120
|
|
|
|
|
|
||||
Earnings per share:
|
|
|
|
||||
Basic
|
$
|
0.35
|
|
|
$
|
0.36
|
|
Diluted
|
$
|
0.35
|
|
|
$
|
0.36
|
|
|
|
|
|
||||
Shares used in the calculation of earnings per share:
|
|
|
|
||||
Basic
|
284,086
|
|
|
284,654
|
|
||
Diluted
|
289,430
|
|
|
290,260
|
|
||
|
|
|
|
||||
Dividends declared and paid per share
|
$
|
0.28
|
|
|
$
|
0.26
|
|
|
Three Months Ended
|
||||||
|
September 27,
2014 |
|
September 28,
2013 |
||||
|
(in thousands)
|
||||||
Net income
|
$
|
99,980
|
|
|
$
|
103,120
|
|
Other comprehensive income, net of tax:
|
|
|
|
||||
Change in net unrealized gains and losses on available-for-sale securities, net of tax benefit (expense) of $0 and $4, respectively
|
(25
|
)
|
|
(8
|
)
|
||
Change in net unrealized gains and losses on cash flow hedges, net of tax benefit (expense) of $470 and $(290), respectively
|
(1,575
|
)
|
|
1,224
|
|
||
Change in net unrealized gains and losses on post-retirement benefits, net of tax benefit (expense) of $(121) and $(75), respectively
|
239
|
|
|
284
|
|
||
Tax effect of the unrealized exchange gains and losses on long-term intercompany receivables
|
(540
|
)
|
|
138
|
|
||
Other comprehensive income (loss), net
|
(1,901
|
)
|
|
1,638
|
|
||
Total comprehensive income
|
$
|
98,079
|
|
|
$
|
104,758
|
|
|
Three Months Ended
|
||||||
|
September 27,
2014 |
|
September 28,
2013 |
||||
|
(in thousands)
|
||||||
Cash flows from operating activities:
|
|
|
|
||||
Net income
|
$
|
99,980
|
|
|
$
|
103,120
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
|
||||
Stock-based compensation
|
22,420
|
|
|
18,740
|
|
||
Depreciation and amortization
|
63,693
|
|
|
51,133
|
|
||
Deferred taxes
|
6,207
|
|
|
25,529
|
|
||
Loss (gain) from sale of property, plant and equipment
|
244
|
|
|
36
|
|
||
Tax benefit (shortfall) related to stock-based compensation
|
1,610
|
|
|
(3,488
|
)
|
||
Impairment of long-lived assets
|
10,226
|
|
|
—
|
|
||
Excess tax benefit from stock-based compensation
|
(2,249
|
)
|
|
(1,697
|
)
|
||
Changes in assets and liabilities:
|
|
|
|
||||
Accounts receivable
|
13,896
|
|
|
(12,450
|
)
|
||
Inventories
|
(15,650
|
)
|
|
(2,301
|
)
|
||
Other current assets
|
(24,974
|
)
|
|
(18,546
|
)
|
||
Accounts payable
|
4,455
|
|
|
(9,162
|
)
|
||
Income taxes payable
|
(12,289
|
)
|
|
11,393
|
|
||
Deferred revenue on shipments to distributors
|
1,087
|
|
|
622
|
|
||
All other accrued liabilities
|
(51,659
|
)
|
|
(67,035
|
)
|
||
Net cash provided by (used in) operating activities
|
116,997
|
|
|
95,894
|
|
||
|
|
|
|
||||
Cash flows from investing activities:
|
|
|
|
||||
Purchase of property, plant and equipment
|
(31,686
|
)
|
|
(36,329
|
)
|
||
Proceeds from sale of property, plant and equipment
|
212
|
|
|
3,048
|
|
||
Purchases of available-for-sale securities
|
(25,142
|
)
|
|
—
|
|
||
Net cash provided by (used in) investing activities
|
(56,616
|
)
|
|
(33,281
|
)
|
||
|
|
|
|
||||
Cash flows from financing activities:
|
|
|
|
||||
Excess tax benefit from stock-based compensation
|
2,249
|
|
|
1,697
|
|
||
Repayment of notes payable
|
(437
|
)
|
|
—
|
|
||
Issuance of debt
|
—
|
|
|
100
|
|
||
Net issuance of restricted stock units
|
(8,038
|
)
|
|
(6,966
|
)
|
||
Proceeds from stock options exercised
|
9,704
|
|
|
5,247
|
|
||
Repurchase of common stock
|
(62,685
|
)
|
|
(154,386
|
)
|
||
Dividends paid
|
(79,763
|
)
|
|
(73,744
|
)
|
||
Net cash provided by (used in) financing activities
|
(138,970
|
)
|
|
(228,052
|
)
|
||
Net increase (decrease) in cash and cash equivalents
|
(78,589
|
)
|
|
(165,439
|
)
|
||
Cash and cash equivalents:
|
|
|
|
||||
Beginning of period
|
1,322,472
|
|
|
1,174,986
|
|
||
End of period
|
$
|
1,243,883
|
|
|
$
|
1,009,547
|
|
Supplemental disclosures of cash flow information:
|
|
|
|
||||
Cash paid (refunded), net during the period for income taxes
|
$
|
8,581
|
|
|
$
|
433
|
|
Cash paid for interest
|
$
|
8,452
|
|
|
$
|
8,302
|
|
Noncash financing and investing activities:
|
|
|
|
||||
Accounts payable related to property, plant and equipment purchases
|
$
|
4,290
|
|
|
$
|
21,725
|
|
|
September 27,
2014 |
|
June 28,
2014 |
||||
Accounts Receivable:
|
(in thousands)
|
||||||
Accounts receivable
|
$
|
302,111
|
|
|
$
|
313,578
|
|
Returns and allowances
|
(20,179
|
)
|
|
(17,750
|
)
|
||
|
$
|
281,932
|
|
|
$
|
295,828
|
|
|
September 27,
2014 |
|
June 28,
2014 |
||||
Inventories:
|
(in thousands)
|
||||||
Raw materials
|
$
|
11,639
|
|
|
$
|
14,774
|
|
Work-in-process
|
200,659
|
|
|
188,198
|
|
||
Finished goods
|
92,810
|
|
|
86,320
|
|
||
|
$
|
305,108
|
|
|
$
|
289,292
|
|
|
September 27,
2014 |
|
June 28,
2014 |
||||
Property, plant and equipment:
|
(in thousands)
|
||||||
Land
|
$
|
62,093
|
|
|
$
|
62,093
|
|
Buildings and building improvements
|
384,468
|
|
|
378,477
|
|
||
Machinery and equipment
|
2,144,586
|
|
|
2,134,813
|
|
||
|
2,591,147
|
|
|
2,575,383
|
|
||
Less: accumulated depreciation and amortization
|
(1,287,286
|
)
|
|
(1,243,864
|
)
|
||
|
$
|
1,303,861
|
|
|
$
|
1,331,519
|
|
|
September 27,
2014 |
|
June 28,
2014 |
||||
Accrued salary and related expenses:
|
(in thousands)
|
||||||
Accrued bonus
|
$
|
24,029
|
|
|
$
|
88,192
|
|
Accrued vacation
|
43,130
|
|
|
43,528
|
|
||
Accrued salaries
|
11,665
|
|
|
18,242
|
|
||
Other
|
47,800
|
|
|
36,770
|
|
||
|
$
|
126,624
|
|
|
$
|
186,732
|
|
|
As of September 27, 2014
|
|
As of June 28, 2014
|
||||||||||||||||||||||||||||
|
Fair Value
Measurements Using
|
|
Total
Balance
|
|
Fair Value
Measurements Using
|
|
Total
Balance |
||||||||||||||||||||||||
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
||||||||||||||||||
|
(in thousands)
|
||||||||||||||||||||||||||||||
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Money market funds (1)
|
$
|
891,158
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
891,158
|
|
|
$
|
971,868
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
971,868
|
|
U.S. treasury bills (2)
|
—
|
|
|
75,094
|
|
|
—
|
|
|
75,094
|
|
|
—
|
|
|
49,953
|
|
|
—
|
|
|
49,953
|
|
||||||||
Foreign currency forward contracts (3)
|
—
|
|
|
259
|
|
|
—
|
|
|
259
|
|
|
—
|
|
|
316
|
|
|
—
|
|
|
316
|
|
||||||||
Total Assets
|
$
|
891,158
|
|
|
$
|
75,353
|
|
|
$
|
—
|
|
|
$
|
966,511
|
|
|
$
|
971,868
|
|
|
$
|
50,269
|
|
|
$
|
—
|
|
|
$
|
1,022,137
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Foreign currency forward contracts (4)
|
$
|
—
|
|
|
$
|
2,366
|
|
|
$
|
—
|
|
|
$
|
2,366
|
|
|
$
|
—
|
|
|
$
|
438
|
|
|
$
|
—
|
|
|
$
|
438
|
|
Contingent Consideration (4)
|
—
|
|
|
—
|
|
|
1,000
|
|
|
1,000
|
|
|
—
|
|
|
—
|
|
|
3,215
|
|
|
3,215
|
|
||||||||
Total Liabilities
|
$
|
—
|
|
|
$
|
2,366
|
|
|
$
|
1,000
|
|
|
$
|
3,366
|
|
|
$
|
—
|
|
|
$
|
438
|
|
|
$
|
3,215
|
|
|
$
|
3,653
|
|
Fair Value Measured and Recorded Using Significant Unobservable Inputs (Level 3)
|
||||||||
|
|
|
|
|
||||
|
|
September 27,
2014 |
|
September 28,
2013 |
||||
Contingent Consideration
|
|
(in thousands)
|
||||||
Beginning balance
|
|
$
|
3,215
|
|
|
$
|
8,577
|
|
Total gains or losses (realized and unrealized):
|
|
|
|
|
||||
Included in earnings
|
|
384
|
|
|
208
|
|
||
Payments
|
|
(2,599
|
)
|
|
—
|
|
||
Ending balance
|
|
$
|
1,000
|
|
|
$
|
8,785
|
|
|
|
|
|
|
||||
Changes in unrealized losses (gains) included in earnings related to liabilities still held as of period end
|
|
$
|
384
|
|
|
$
|
208
|
|
|
September 27, 2014
|
|
June 28, 2014
|
||||||||||||||||||||||||||||
|
Amortized Cost
|
|
Gross Unrealized Gain
|
|
Gross Unrealized Loss
|
|
Estimated Fair Value
|
|
Amortized Cost
|
|
Gross Unrealized Gain
|
|
Gross Unrealized Loss
|
|
Estimated Fair Value
|
||||||||||||||||
|
(in thousands)
|
||||||||||||||||||||||||||||||
Available-for-sale investments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Government agency securities
|
$
|
75,020
|
|
|
$
|
86
|
|
|
$
|
(12
|
)
|
|
$
|
75,094
|
|
|
$
|
49,853
|
|
|
$
|
100
|
|
|
$
|
—
|
|
|
$
|
49,953
|
|
Total available-for-sale investments
|
$
|
75,020
|
|
|
$
|
86
|
|
|
$
|
(12
|
)
|
|
$
|
75,094
|
|
|
$
|
49,853
|
|
|
$
|
100
|
|
|
$
|
—
|
|
|
$
|
49,953
|
|
|
September 27,
2014 |
|
June 28,
2014 |
||||
|
(in thousands)
|
||||||
2.5% fixed rate notes due November 2018
|
$
|
500,000
|
|
|
$
|
500,000
|
|
3.375% fixed rate notes due March 2023
|
500,000
|
|
|
500,000
|
|
||
Notes denominated in Euro
|
|
|
|
||||
Amortizing floating rate notes (EURIBOR plus 1.5%) due up to June 30, 2014
|
—
|
|
|
372
|
|
||
Term fixed rate notes (2.0%) due on September 30, 2015
|
1,026
|
|
|
1,026
|
|
||
Total
|
1,001,026
|
|
|
1,001,398
|
|
||
Less: Current portion
|
—
|
|
|
(372
|
)
|
||
Total long-term debt
|
$
|
1,001,026
|
|
|
$
|
1,001,026
|
|
|
Three Months Ended
|
||||||||||||||||||||||||||||||
|
September 27, 2014
|
|
September 28, 2013
|
||||||||||||||||||||||||||||
|
Stock Options
|
|
Restricted Stock Units
|
|
Employee Stock Purchase Plan
|
|
Total
|
|
Stock Options
|
|
Restricted Stock Units
|
|
Employee Stock Purchase Plan
|
|
Total
|
||||||||||||||||
|
(in thousands)
|
||||||||||||||||||||||||||||||
Cost of goods sold
|
$
|
339
|
|
|
$
|
1,974
|
|
|
$
|
524
|
|
|
$
|
2,837
|
|
|
$
|
349
|
|
|
$
|
1,918
|
|
|
$
|
475
|
|
|
$
|
2,742
|
|
Research and development
|
2,147
|
|
|
8,832
|
|
|
1,343
|
|
|
12,322
|
|
|
1,836
|
|
|
6,440
|
|
|
1,322
|
|
|
9,598
|
|
||||||||
Selling, general and administrative
|
1,429
|
|
|
5,224
|
|
|
608
|
|
|
7,261
|
|
|
1,264
|
|
|
4,527
|
|
|
609
|
|
|
6,400
|
|
||||||||
Pre-tax stock-based compensation expense
|
$
|
3,915
|
|
|
$
|
16,030
|
|
|
$
|
2,475
|
|
|
$
|
22,420
|
|
|
$
|
3,449
|
|
|
$
|
12,885
|
|
|
$
|
2,406
|
|
|
$
|
18,740
|
|
Less: income tax effect
|
|
|
|
|
|
|
3,272
|
|
|
|
|
|
|
|
|
2,729
|
|
||||||||||||||
Net stock-based compensation expense
|
|
|
|
|
|
|
|
|
$
|
19,148
|
|
|
|
|
|
|
|
|
$
|
16,011
|
|
|
Stock Options
|
||||
|
Three Months Ended
|
||||
|
September 27,
2014 |
|
September 28,
2013 |
||
Expected holding period (in years)
|
4.8
|
|
|
5.4
|
|
Risk-free interest rate
|
1.6
|
%
|
|
1.4
|
%
|
Expected stock price volatility
|
26.7
|
%
|
|
35.0
|
%
|
Dividend yield
|
3.1
|
%
|
|
3.1
|
%
|
|
Number of
Shares
|
|
Weighted Average Exercise Price
|
|
Weighted Average Remaining Contractual Term (in Years)
|
|
Aggregate Intrinsic Value (1)
|
|||||
Balance at June 28, 2014
|
16,163,644
|
|
|
$
|
25.74
|
|
|
|
|
|
||
Options Granted
|
55,576
|
|
|
32.76
|
|
|
|
|
|
|||
Options Exercised
|
(524,614
|
)
|
|
16.91
|
|
|
|
|
|
|||
Options Cancelled
|
(391,851
|
)
|
|
36.80
|
|
|
|
|
|
|||
Balance at September 27, 2014
|
15,302,755
|
|
|
$
|
25.78
|
|
|
3.5
|
|
$
|
99,141,987
|
|
Exercisable, September 27, 2014
|
7,068,084
|
|
|
$
|
25.79
|
|
|
1.8
|
|
$
|
56,266,217
|
|
Vested and expected to vest, September 27, 2014
|
14,551,614
|
|
|
$
|
25.70
|
|
|
3.4
|
|
$
|
96,124,051
|
|
(1)
|
Aggregate intrinsic value represents the difference between the exercise price and the closing price per share of the Company’s common stock on September 26, 2014, the last business day preceding the fiscal quarter-end, multiplied by the number of options outstanding, exercisable or vested and expected to vest as of September 27, 2014.
|
|
Number of
Shares
|
|
Weighted Average
Remaining Contractual Term (in Years) |
|
Aggregate Intrinsic
Value (1)
|
|||
Balance at June 28, 2014
|
7,695,131
|
|
|
|
|
|
||
Restricted stock units granted
|
2,462,214
|
|
|
|
|
|
||
Restricted stock units released
|
(675,621
|
)
|
|
|
|
|
||
Restricted stock units cancelled
|
(216,225
|
)
|
|
|
|
|
||
Balance at September 27, 2014
|
9,265,499
|
|
|
3.1
|
|
$
|
308,410,676
|
|
Outstanding and expected to vest, September 27, 2014
|
8,602,824
|
|
|
3.0
|
|
$
|
265,913,281
|
|
(1)
|
Aggregate intrinsic value for RSUs represents the closing price per share of the Company’s common stock on September 26, 2014, the last business day preceding the fiscal quarter-end, multiplied by the number of RSUs outstanding or expected to vest as of September 27, 2014.
|
|
Three Months Ended
|
||||||
|
September 27,
2014 |
|
September 28,
2013 |
||||
|
(in thousands, except per share data)
|
||||||
Numerator for basic earnings per share and diluted earnings per share
|
|
|
|
||||
Net income
|
$
|
99,980
|
|
|
$
|
103,120
|
|
|
|
|
|
||||
Denominator for basic earnings per share
|
284,086
|
|
|
284,654
|
|
||
Effect of dilutive securities:
|
|
|
|
||||
Stock options, ESPP and RSUs
|
5,344
|
|
|
5,606
|
|
||
Denominator for diluted earnings per share
|
289,430
|
|
|
290,260
|
|
||
|
|
|
|
||||
Earnings per share: basic
|
|
|
|
||||
Basic
|
$
|
0.35
|
|
|
$
|
0.36
|
|
Diluted
|
$
|
0.35
|
|
|
$
|
0.36
|
|
•
|
the nature of products and services;
|
•
|
the nature of the production processes;
|
•
|
the type or class of customer for their products and services; and
|
•
|
the methods used to distribute their products or provide their services.
|
•
|
the sale of analog and mixed signal integrated circuits is the primary source of revenue for each of the Company’s three operating segments;
|
•
|
the integrated circuits sold by each of the Company’s operating segments are manufactured using similar semiconductor manufacturing processes;
|
•
|
the integrated circuits marketed by each of the Company’s operating segments are sold to the same types of customers; and
|
•
|
all of the Company’s integrated circuits are sold through a centralized sales force and common wholesale distributors.
|
|
Three Months Ended
|
||||||
|
September 27,
2014 |
|
September 28,
2013 |
||||
|
(in thousands)
|
||||||
United States
|
$
|
74,595
|
|
|
$
|
89,099
|
|
China
|
240,016
|
|
|
233,898
|
|
||
Rest of Asia
|
165,433
|
|
|
173,382
|
|
||
Europe
|
83,965
|
|
|
72,626
|
|
||
Rest of World
|
16,266
|
|
|
16,236
|
|
||
|
$
|
580,275
|
|
|
$
|
585,241
|
|
|
September 27,
2014 |
|
June 28,
2014 |
||||
|
(in thousands)
|
||||||
United States
|
$
|
973,939
|
|
|
$
|
1,035,699
|
|
Philippines
|
178,352
|
|
|
172,823
|
|
||
Rest of World
|
151,570
|
|
|
122,997
|
|
||
|
$
|
1,303,861
|
|
|
$
|
1,331,519
|
|
(in thousands)
|
Unrealized gains and losses on intercompany receivables
|
|
Unrealized gains and losses on post-retirement benefits
|
|
Cumulative translation adjustment
|
|
Unrealized gains and losses on cash flow hedges
|
|
Unrealized gains and losses on available-for-sale securities
|
|
Total
|
||||||||||||
June 28, 2014
|
$
|
(5,753
|
)
|
|
$
|
(10,373
|
)
|
|
$
|
(1,136
|
)
|
|
$
|
(11
|
)
|
|
$
|
100
|
|
|
$
|
(17,173
|
)
|
Other comprehensive income (loss) before reclassifications
|
—
|
|
|
—
|
|
|
—
|
|
|
(1,874
|
)
|
|
(25
|
)
|
|
(1,899
|
)
|
||||||
Amounts reclassified out of accumulated other comprehensive loss (income)
|
—
|
|
|
360
|
|
|
—
|
|
|
(171
|
)
|
|
—
|
|
|
189
|
|
||||||
Tax effects
|
(540
|
)
|
|
(121
|
)
|
|
—
|
|
|
470
|
|
|
—
|
|
|
(191
|
)
|
||||||
Other comprehensive income (loss)
|
(540
|
)
|
|
239
|
|
|
—
|
|
|
(1,575
|
)
|
|
(25
|
)
|
|
(1,901
|
)
|
||||||
September 27, 2014
|
$
|
(6,293
|
)
|
|
$
|
(10,134
|
)
|
|
$
|
(1,136
|
)
|
|
$
|
(1,586
|
)
|
|
$
|
75
|
|
|
$
|
(19,074
|
)
|
|
September 27,
2014 |
|
September 28,
2013 |
||||
Product warranty liability
|
(in thousands)
|
||||||
Beginning balance
|
$
|
21,296
|
|
|
$
|
3,075
|
|
Accruals for warranties
|
57
|
|
|
498
|
|
||
Payments
|
(1,617
|
)
|
|
(843
|
)
|
||
Changes in estimate
|
81
|
|
|
(378
|
)
|
||
Ending balance
|
$
|
19,817
|
|
|
$
|
2,352
|
|
|
|
|
|
||||
Less: Current portion
|
11,217
|
|
|
2,352
|
|
||
Non-current portion
|
$
|
8,600
|
|
|
$
|
—
|
|
|
|
(in thousands)
|
||
Cash consideration for 100% of outstanding common stock of Volterra at $23 per share
|
|
$
|
593,250
|
|
Cash consideration for vested options settlement
|
|
21,756
|
|
|
Total preliminary purchase price
|
|
$
|
615,006
|
|
|
Volterra
|
||
|
(in thousands)
|
||
Cash and cash equivalents and short-term investments
|
$
|
163,500
|
|
Accounts receivable
|
23,453
|
|
|
Inventories
|
33,339
|
|
|
Other tangible assets
|
17,151
|
|
|
Accrued expenses
|
(35,343
|
)
|
|
Income taxes payable
|
(23,241
|
)
|
|
Other liabilities assumed
|
(20,149
|
)
|
|
Net tangible assets
|
158,710
|
|
|
Amortizable intangible assets
|
226,900
|
|
|
In-process research and development ("IPR&D")
|
56,200
|
|
|
Goodwill
|
174,894
|
|
|
Substitution of stock-based compensation awards
|
(1,698
|
)
|
|
Total purchase price
|
$
|
615,006
|
|
|
Volterra acquisition
|
||||
|
Fair value
(in thousands)
|
|
Weighted average useful life (in years)
|
||
Intellectual property
|
$
|
192,500
|
|
|
4.9
|
Customer relationships
|
24,600
|
|
|
9.6
|
|
Trade name
|
6,400
|
|
|
4.0
|
|
Backlog
|
900
|
|
|
0.4
|
|
Patents
|
2,500
|
|
|
4.8
|
|
Total amortizable intangible assets
|
$
|
226,900
|
|
|
|
|
Goodwill
|
||
|
(in thousands)
|
||
Balance at June 28, 2014
|
$
|
596,637
|
|
Adjustments
|
(1,196
|
)
|
|
Balance at September 27, 2014
|
$
|
595,441
|
|
Asset
|
|
Life
|
Intellectual property
|
|
3 months-10 years
|
Customer relationships
|
|
5-10 years
|
Trade name
|
|
3-4 years
|
Backlog
|
|
4 months
|
Patents
|
|
5 years
|
|
September 27,
2014 |
|
June 28,
2014 |
||||||||||||||||||||
|
Original
Cost
|
|
Accumulated
Amortization
|
|
Net
|
|
Original
Cost
|
|
Accumulated
Amortization
|
|
Net
|
||||||||||||
|
(in thousands)
|
||||||||||||||||||||||
Intellectual property
|
$
|
435,962
|
|
|
$
|
220,389
|
|
|
$
|
215,573
|
|
|
$
|
435,962
|
|
|
$
|
201,581
|
|
|
$
|
234,381
|
|
Customer relationships
|
120,230
|
|
|
72,786
|
|
|
47,444
|
|
|
120,230
|
|
|
69,064
|
|
|
51,166
|
|
||||||
Tradename
|
8,500
|
|
|
3,686
|
|
|
4,814
|
|
|
8,500
|
|
|
3,269
|
|
|
5,231
|
|
||||||
Backlog
|
—
|
|
|
—
|
|
|
—
|
|
|
1,000
|
|
|
1,000
|
|
|
—
|
|
||||||
Patent
|
2,500
|
|
|
516
|
|
|
1,984
|
|
|
2,500
|
|
|
386
|
|
|
2,114
|
|
||||||
Total amortizable purchased intangible assets
|
567,192
|
|
|
297,377
|
|
|
269,815
|
|
|
568,192
|
|
|
275,300
|
|
|
292,892
|
|
||||||
IPR&D
|
68,102
|
|
|
—
|
|
|
68,102
|
|
|
68,102
|
|
|
—
|
|
|
68,102
|
|
||||||
Total purchased intangible assets
|
$
|
635,294
|
|
|
$
|
297,377
|
|
|
$
|
337,917
|
|
|
$
|
636,294
|
|
|
$
|
275,300
|
|
|
$
|
360,994
|
|
|
Three Months Ended
|
||||||
|
September 27,
2014 |
|
September 28,
2013 |
||||
|
(in thousands)
|
||||||
Cost of goods sold
|
$
|
18,750
|
|
|
$
|
8,092
|
|
Intangible asset amortization
|
4,327
|
|
|
3,436
|
|
||
Total intangible asset amortization expenses
|
$
|
23,077
|
|
|
$
|
11,528
|
|
Fiscal Year
|
|
Amount
|
||
|
|
(in thousands)
|
||
Remaining nine months of 2015
|
|
$
|
67,366
|
|
2016
|
|
74,454
|
|
|
2017
|
|
61,782
|
|
|
2018
|
|
41,927
|
|
|
2019
|
|
13,278
|
|
|
2020
|
|
3,358
|
|
|
Thereafter
|
|
7,650
|
|
|
Total intangible assets
|
|
$
|
269,815
|
|
|
Three Months Ended
|
||||
|
September 27,
2014 |
|
September 28,
2013 |
||
|
|
||||
Net revenues
|
100.0
|
%
|
|
100.0
|
%
|
Cost of goods sold
|
41.6
|
%
|
|
40.7
|
%
|
Gross margin
|
58.4
|
%
|
|
59.3
|
%
|
Operating expenses:
|
|
|
|
||
Research and development
|
24.2
|
%
|
|
22.2
|
%
|
Selling, general and administrative
|
13.8
|
%
|
|
13.2
|
%
|
Intangible asset amortization
|
0.7
|
%
|
|
0.6
|
%
|
Impairment of long-lived assets
|
1.8
|
%
|
|
—
|
%
|
Severance and restructuring expenses
|
0.2
|
%
|
|
0.9
|
%
|
Other operating expenses (income), net
|
0.3
|
%
|
|
0.5
|
%
|
Total operating expenses
|
41.0
|
%
|
|
37.4
|
%
|
Operating income
|
17.4
|
%
|
|
21.9
|
%
|
Interest and other income (expense), net
|
(1.1
|
)%
|
|
(0.6
|
)%
|
Income before provision for income taxes
|
16.3
|
%
|
|
21.3
|
%
|
Income tax provision (benefit)
|
(0.9
|
)%
|
|
3.8
|
%
|
Net income
|
17.2
|
%
|
|
17.5
|
%
|
|
Three Months Ended
|
||||
|
September 27,
2014 |
|
September 28,
2013 |
||
|
|
||||
Cost of goods sold
|
0.5
|
%
|
|
0.5
|
%
|
Research and development
|
2.1
|
%
|
|
1.6
|
%
|
Selling, general and administrative
|
1.3
|
%
|
|
1.1
|
%
|
|
3.9
|
%
|
|
3.2
|
%
|
|
Three Months Ended
|
||||||
|
September 27,
2014 |
|
September 28,
2013 |
||||
|
(in thousands)
|
||||||
Net cash provided by (used in) operating activities
|
$
|
116,997
|
|
|
$
|
95,894
|
|
Net cash provided by (used in) investing activities
|
(56,616
|
)
|
|
(33,281
|
)
|
||
Net cash provided by (used in) financing activities
|
(138,970
|
)
|
|
(228,052
|
)
|
||
Net increase (decrease) in cash and cash equivalents
|
$
|
(78,589
|
)
|
|
$
|
(165,439
|
)
|
|
Issuer Repurchases of Equity Securities
|
||||||||||||
|
(in thousands, except per share amounts)
|
||||||||||||
|
Total Number of Shares Purchased
|
|
Average Price Paid per Share
|
|
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs
|
|
Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs
|
||||||
Jun. 29, 2014 - Jul 26, 2014
|
323
|
|
|
$
|
33.97
|
|
|
323
|
|
|
$
|
750,871
|
|
Jul 27, 2014 - Aug. 23, 2014
|
589
|
|
|
30.34
|
|
|
589
|
|
|
733,006
|
|
||
Aug. 24, 2014 - Sep. 27, 2014
|
1,093
|
|
|
30.95
|
|
|
1,093
|
|
|
699,183
|
|
||
Total for the quarter
|
2,005
|
|
|
$
|
31.26
|
|
|
2,005
|
|
|
$
|
699,183
|
|
3.4
|
Amended and Restated Bylaws
(1)
|
10.3
|
Performance Share Agreement
(2)
|
31.1
|
Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act
|
31.2
|
Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act
|
32.1
|
Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350
(3)
|
32.2
|
Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350
(3)
|
101.INS
|
XBRL Instance Document
|
101.SCH
|
XBRL Taxonomy Extension Schema Document
|
101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
101.DEF
|
XBRL Taxonomy Extension Definition Linkbase Document
|
101.LAB
|
XBRL Taxonomy Extension Label Linkbase Document
|
101.PRE
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
(1) Incorporated by reference to the Company’s Current Report on Form 8-K filed with the SEC on September 12, 2014.
|
||||
(2) Management contract or compensatory plan or arrangement.
|
||||
(3) This exhibit is being furnished rather than filed and shall not be deemed incorporated by reference into any filing, in accordance with Item 601 of Regulation S-K.
|
October 24, 2014
|
|
MAXIM INTEGRATED PRODUCTS, INC.
|
|
|
|
|
|
By:/s/ David A. Caron
|
|
|
|
|
|
David A. Caron
|
|
|
Vice President and Principal Accounting Officer
|
|
|
(Chief Accounting Officer and Duly Authorized Officer)
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|
No information found
Customers
Customer name | Ticker |
---|---|
IES Holdings, Inc. | IESC |
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|